Exclusive news, analysis, and commentary on Big Pharma, hospitals, and biotech.
Novo Nordisk has announced a new drug in its pipeline performed much better than Wegovy in helping participants to lose weight.
The company’s stock ran higher after the company buoyed investors’ hopes that its technology will boost a lineup of new popular drugs.
The investigation is targeting so-called middlemen that broker deals between hospitals and pharmaceutical companies.
The growing sector scored its second-highest month ever for total money-raising.
The company, now one of Europe’s biggest, is trying to keep supply up with still-astronomical demand.
After a solid 2023, shares of WW International just experienced their worst month ever, falling nearly 60% amid signs of waning demand.
Many of the medicines are the most popular in the sector, including popular weight loss drugs Ozempic and Mounjaro.
The US government designed a program to incentivize the development of treatments for rare tropical diseases. Big Pharma had other plans.